MEMANTALE [Memantine]

Dosage: Memantine starting dosage is 5 mg daily, which can slowly be tapered up to 10-15 mg, depending on the indication.

Note: Memantine half-life is 60-100 hours, therefore caution should be exerted when tapering up after first days of use.

Side effects: Memantine is, in general, well-tolerated. Side effects are likely to occur if the dosage accumulated in the body is too high. The side effects include confusion, drowsiness, headache, agitation and hallucination.

Country of Manufacture: Russia

Availability: in stock

Synthesised by Eli Lilly and Company in 1968, Memantine is one of the few pharmaceuticals approved by FDA for treatment of moderate-to-severe Alzheimer's disease. Off-label use of Memantine also includes reversing tolerance for caffeine, nicotine and opioids; it might also be taken for a treatment of generalised anxiety disorder. 

In the body Memantine reduces certain types of brain activity by binding to NMDA receptors and blocking the activity of glutamate. As a result, Memantine upregulates receptors in the brain and has a cognitive-enhancing effect.

Country of Manufacture: Russia

Type: Nootropics